SCHEMBL3645101

SCHEMBL3645101

O=C(NCCNC(=O)c1cccc2occc12)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.48
POLB P06746 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.44
CYP1A1 P04798 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP1B1 Q16678 1/20 0.44
MAOB P27338 1/20 0.44
GAA P10253 1/20 0.44
KMT2A Q03164 2/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
EPHX2 P34913 1/20 0.43
PRSS1 P07477 1/20 0.43
CTSG P08311 1/20 0.43
CTRB1 P17538 1/20 0.43
CMA1 P23946 1/20 0.43
MEN1 O00255 1/20 0.43
MRGPRX1 Q96LB2 1/20 0.43
RECQL P46063 1/20 0.42
NAAA Q02083 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3644916 0.88 KMT2A (0.56) SMN1; SMN2GAAKMT2ANPC1RAB9A
SCHEMBL3644777 0.86 TRPV1 (0.44) POLBMAOBGAAKMT2ANPC1
SCHEMBL3645922 0.84 MAOB (0.45) LMNAPOLBSMN1; SMN2MAOBGAA
SCHEMBL3645103 0.84 CTDSP1 (0.57) LMNAPOLBGAAKMT2AMEN1
SCHEMBL3648208 0.84 HPGD (0.46) POLBSMN1; SMN2GAAKMT2ANPC1
SCHEMBL3648211 0.83 NPC1 (0.49) POLBSMN1; SMN2GAAKMT2ANPC1
SCHEMBL3647326 0.83 HPGD (0.44) POLBSMN1; SMN2CYP1A1CYP1A2CYP1B1
SCHEMBL3647331 0.83 MAOB (0.59) LMNAPOLBSMN1; SMN2MAOBGAA
SCHEMBL3645968 0.82 MEN1 (0.47) LMNAPOLBSMN1; SMN2GAAKMT2A
SCHEMBL3645917 0.82 TSHR (0.41) LMNAPOLBSMN1; SMN2MAOBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2188282-A2 1,2-DIAMIDO-ETHYLENE DERIVATIVES AS OREXIN ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2010-05-26 EP claimed
WO-2009022311-A2 1,2-DIAMIDO-ETHYLENE DERIVATIVES AS OREXIN ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2009-02-19 WO claimed
EP-2188282-B1 1,2-DIAMIDO-ETHYLENE DERIVATIVES AS OREXIN ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2013-01-23 EP disclosed
EP-2188282-A2 1,2-DIAMIDO-ETHYLENE DERIVATIVES AS OREXIN ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2010-05-26 EP disclosed
WO-2009022311-A2 1,2-DIAMIDO-ETHYLENE DERIVATIVES AS OREXIN ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2009-02-19 WO disclosed